MYD88 L265P Mutation Is a Possible Unfavorable Prognostic Factor in Patients with Diffuse B-Cell Lymphoma

被引：2

作者：

Sidorova, Anna A. ^{[1
]}

Zvonkov, Eugene E. ^{[1
]}

Sudarikov, Andrey B. ^{[1
]}

Severina, Nataliya A. ^{[2
]}

Kovrigina, Alla M. ^{[1
]}

Troitskaya, Vera V. ^{[1
]}

Savchenko, Valeri G. ^{[1
]}

机构：

[1] Natl Res Ctr Hematol, Moscow, Russia

[2] Natl Res Ctr Hematol, Mol Hematol, Moscow, Russia

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

10.1182/blood.V126.23.5051.5051

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] MYD88 (L265P) MUTATION IS ASSOCIATED WITH AN UNFAVORABLE OUTCOME OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Hattori, K.
Sakata-Yanagimoto, M.
Okoshi, Y.
Goshima, Y.
Yanagimoto, S.
Nakamoto-Matsubara, R.
Sato, T.
Noguchi, M.
Takano, S.
Ishikawa, E.
Yamamoto, T.
Matsumura, A.
Chiba, S.
HAEMATOLOGICA, 2016, 101 : 392 - 393
[22] High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type
Pham-Ledard, Anne
Beylot-Barry, Marie
Barbe, Coralie
Leduc, Marion
Petrella, Tony
Vergier, Beatrice
Martinez, Fabian
Cappellen, David
Merlio, Jean-Philippe
Grange, Florent
JAMA DERMATOLOGY, 2014, 150 (11) : 1173 - 1179
[23] MYD88 L265P mutation in Waldenstrom macroglobulinemia
Poulain, Stephanie
Roumier, Christophe
Decambron, Audrey
Renneville, Aline
Herbaux, Charles
Bertrand, Elisabeth
Tricot, Sabine
Daudignon, Agnes
Galiegue-Zouitina, Sylvie
Soenen, Valerie
Theisen, Olivier
Grardel, Nathalie
Nibourel, Olivier
Roche-Lestienne, Catherine
Quesnel, Bruno
Duthilleul, Patrick
Preudhomme, Claude
Leleu, Xavier
BLOOD, 2013, 121 (22) : 4504 - 4511
[24] MYD88 L265P Mutation in Lymphoid Malignancies
Yu, Xinfang
Li, Wei
Deng, Qipan
Li, Ling
Hsi, Eric D.
Young, Ken H.
Zhang, Mingzhi
Li, Yong
CANCER RESEARCH, 2018, 78 (10) : 2457 - 2462
[25] Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia
Insuasti-Beltran, Giovanni
Gale, James M.
Wilson, Carla S.
Foucar, Kathryn
Czuchlewski, David R.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (08) : 1035 - 1041
[26] MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA
Miserocchi, Elisabetta
Ferreri, Andres J. M.
Giuffre, Chiara
Cangi, Maria G.
Francaviglia, Ilaria
Calimeri, Teresa
Ponzoni, Maurilio
Pecciarini, Lorenza
Bandello, Francesco M.
Modorati, Giulio M.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (04): : 679 - 684
[27] Discrepancy of Hans' criteria for clonally related nodal and pericardiac fluid diffuse large B-cell lymphoma with MYD88 L265P mutation
Terao, Toshiki
Sato, Yumiko
Kuroda, Yoshiaki
Haratake, Tomoka
Nishimura, Midori Filiz
Sato, Yasuharu
Kuyama, Shoichi
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024,
[28] MyD88 L265P Mutation-Specific TCR Gene Therapy for Treatment of B-Cell Lymphoma and Leukemia
Cinar, Ozcan
Kloetzel, Peter Michael
Peuker, Caroline Anna
Keller, Ulrich
Pezzutto, Antonio
Busse, Antonia
BLOOD, 2020, 136
[29] MYD88 L265P mutation in intraocular lymphoma: A potential diagnostic marker
Narasimhan, Sandhya
Joshi, Mayur
Parameswaran, Sowmya
Rishi, Pukhraj
Khetan, Vikas
Ganesan, Suganeswari
Biswas, Jyotirmay
Sundaram, Natarajan
Sreenivasan, Janani
Verma, Sonali
Krishnamurthy, Vanitha
Subramanian, Krishnakumar
INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (10) : 2160 - 2165
[30] MYD88 Expression and L265P Mutation in Mature B-Cell Non-Hodgkin Lymphomas
Caner, Vildan
Sen Turk, Nilay
Baris, Ikbal Cansu
Cetin, Gokhan Ozan
Tepeli, Emre
Hacioglu, Sibel
Sari, Ismail
Zencir, Sevil
Dogu, Mehmet Hilmi
Bagci, Gulseren
Keskin, Ali
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2015, 19 (07) : 372 - 378

← 1 2 3 4 5 →